ClearPoint Neuro, Inc. (CLPT) - Net earnings per share (EPS TTM)
ClearPoint Neuro, Inc. (CLPT) maintains an impeccable reputation in precision neurosurgery by implementing high-precision robotic stereotactic systems. The increasing number of gene therapy trials is driving demand for MRI navigation, which is supported by the rolling annual earnings per share. The current level of financial stability determines the -1.20 metric, allowing for an assessment of the business's margin of safety during a period of expensive borrowing.
CLPT (ClearPoint Neuro Inc.): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization indicators:
- business book valuation details:
- debt and liquidity details:
Debt to Equity ClearPoint Neuro, Inc.|CLPT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital ClearPoint|CLPT - Company Cumulative Debt|Debts to Book Capitalization ClearPoint Neuro, Inc.|CLPT - Company Long-Term Indebtedness|Company Short-Term Debts ClearPoint Neuro|Quick Ratio clearpointneuro.com
- net income and valuation multiples indicators:
CLPT - Net Income|Projected Future Earnings ClearPoint Neuro, Inc.|CLPT - P/E Multiple|Future Price to Earnings ClearPoint|CLPT - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio ClearPoint Neuro, Inc.|CLPT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ClearPoint Neuro|CLPT - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months clearpointneuro.com|CLPT - Net earnings per share change in current year|Expected earnings per share growth for next year ClearPoint Neuro, Inc.
Basic company analysis:clearpointneuro.com (CLPT)
ClearPoint Neuro, Inc. (CLPT) maintains a monopoly status in the neuronavigation segment, allowing the company to exercise pricing power and directly impact overall business profitability. The company's net income per share over 12 months is calculated by dividing total net income by the number of securities, reflecting the actual per-unit earnings of the assets and helping investors assess the issuer's fundamental stability during periods of market consolidation.
Direct competitors
BSX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months EW|RMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insulet Corp (PODD)|ZBH (Zimmer Biomet Holdings) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months COO (CooperSurgical)|Net earnings per share for the last 12 months ALGN (Align Technology, Inc.)|GMED (globusmedical.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group Inc TMDX|ATEC - Net earnings per share for the last 12 months|Artivion Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Inc.|IART: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ESTA|BBNX (Beta Bionics) - Net earnings per share (EPS TTM)|IRADIMED Corp (IRMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EMBC|Net earnings per share for the last 12 months Tandem Corp TNDM|Net earnings per share (EPS TTM) AXGN (AxoGen, Inc.)|Net earnings per share (EPS TTM) si-bone.com SIBN|OFIX - Earnings per share for the last twelve months|BVS: Earnings per share for the last twelve months|KIDS (orthopediatrics.com) - Net earnings per share for the last 12 months|Treace Corp - Earnings per share for the trailing year|SRTA (Strata Critical Medical Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months carlsmed.com CARL|Earnings per share for the last twelve months RxSight (RXST)|Stereotaxis Inc (STXS) - Net earnings per share for the trailing year|NeuroStar - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Anika Therapeutics ANIK|InspireMD (NSPR) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZJYL (Jin Medical)|Earnings per share for the last twelve months Vivani Medical Inc|Net earnings per share for the last 12 months Xtant Medical Inc (XTNT)|Net earnings per share (EPS TTM) NMTC|MODD - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Myomo MYO|COCH: Earnings per share for the last 12 months|VVOS: Net earnings per share for the last 12 months|enVVeno Corp - Earnings per share for the last four quarters|SINT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months tenonmed.com|Earnings per share for the last twelve months Lifeward|Earnings per share for the last twelve months AMIX|Net earnings per share (EPS TTM) IVF|BBLG - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) AXNX (Axonics, Inc.)|Net earnings per share (EPS TTM) biolase.com BIOL|DYNT - Earnings per share for the last twelve months|Earnings per share for the trailing year FNA (Paragon 28, Inc.)|invobioscience.com (INVO) - Earnings per share for the last twelve months
